INTRODUCTION
Churg-Strauss syndrome (CSS) is a systemic disorder characterized by asthma, transient pulmonary infiltrates, hypereosinophilia, and systemic vasculitis.
Necrotizing eosinophilic vasculitis of medium-to small-sized blood vessels in multiple organ systems commonly affects the lungs, heart, skin, gastrointestinal tract, and nervous system. Neurological involvement is the second most common manifestation (78% of patients), usually manifesting as peripheral neuropathy. 4) Cerebral hemorrhage and infarction may also occur and are important causes of death. 7) CSS presenting with hemorrhagic stroke is extremely rare. Herein, we report on subarachnoid hemorrhage (SAH) presenting with ruptured intracranial vertebral artery dissection (VAD) and spontaneous intracerebral hemorrhage (ICH) affected by CSS.
CASE REPORT

Case 1
A 39-year-old male patient was admitted to our hospital with complaints of bronchial asthma, rhinitis complicated by nasal polyposis, and eosinophilia in the previous seven months. He was treated with an inhalation corticosteroid, a long-acting β-stimulant, and an oral pranlukast for the asthma. He had no history of smoking or hypertension. Two months later, he suffered from diffuse arthralgia, persistent slight fever, and weight loss. Erythematosus vesiculopurpura skin rash on the dorsal aspect of the both lower leg was observed on the general physical examination. (Fig. 2B) , and on day four after surgery, the catheter was removed from the patient.
At 16 days after treatment, the patient was transferred to the Department of Rehabilitation with a Glasgow
Outcome Scale (GOS) score of 3.
During more than one year of follow up, the patient was treated first with oral prednisolone, and then changed to deflazacort. Follow up blood tests showed a normal peripheral eosinophil count (100 per µl, the lungs, heart, peripheral nervous system, kidney, lymph nodes, muscle, and skin. 16) In our two present cases, the clinicopathologic findings of Case 1 were compatible with the vasculitic phase, and those of Case 2 were compatible with the eosinophilic phase.
Peripheral neuropathy is the second most common manifestation (65-75%). 4) Mononeuritis multiplex is the most frequent finding. 4) The peroneal nerve is commonly involved, however, the ulnar, radial, median and tibial nerves may also be involved. According to reviews of the literature, intracranial hemorrhage in association with Churg-Strauss syndrome has rarely been reported ( ANCA is thought to be involved in intracranial hemorrhage, such as organ system manifestations, including nephropathy, peripheral neuropathy, and purpura.
In review of previously described cases that presented cerebral hemorrhage in patients with CSS, in almost all patients, including our cases, cerebral hemorrhage occurred in phase of active disease. This is pointed out by the presence of hypereosinophilia and increased blood inflammatory markers. Also, in our cases, ECP, a marker of disease activity, was elevated.
These observations could be a differential diagnostic point with other causes of cerebral hemorrhage, such as hypertensive ICH.
Cyclophosphamide combined with glucocorticoids is the standard therapy for remission induction in patients with CSS. These treatments are also indicated in patients with CNS involvement. 16) In patients already diagnosed with CSS, if new neurological presentations develop, the possibility of ICH should be considered.
Also, in patients with a history of asthma and allergic rhinitis, unknown causes of a stroke may be a complication of CSS. This is important because cerebral involvement is a major cause of morbidity and mortality.
CONCLUSION
We report on two cases of SAH and ICH, as a presentation of CSS. Despite being rare, SAH and ICH can be presenting features of vasculitis associated with CSS. In this regard, CSS vasculitis should be considered in the differential diagnosis of hemorrhagic stroke, because prompt management of ICH in CSS, which was performed immediately after diagnosis, can minimize morbidity and mortality.
